S. Marks, D. Ciliska, and A. Jull. Evidence-based nursing, 9 (4):
100-4(October 2006)4369<m:linebreak></m:linebreak>LR: 20071115; PUBM: Print; JID: 9815947; ppublish;<m:linebreak></m:linebreak>Critical appraisal.
F. Ambrogi, E. Biganzoli, and P. Boracchi. Statistics in medicine, 27 (30):
6407-25(December 2008)4677<m:linebreak></m:linebreak>JID: 8215016; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
M. Bradburn, J. Deeks, J. Berlin, and A. Localio. Statistics in medicine, 26 (1):
53-77(January 2007)6691<m:linebreak></m:linebreak>LR: 20071115; GR: U18 HS10399/HS/AHRQ HHS/United States; JID: 8215016; 0 (Pharmaceutical Preparations); ppublish;<m:linebreak></m:linebreak>Metaanàlisi.
A. Beswick, K. Rees, P. Dieppe, S. Ayis, R. Gooberman-Hill, J. Horwood, and S. Ebrahim. Lancet, 371 (9614):
725-35(March 2008)4993<m:linebreak></m:linebreak>LR: 20081120; JID: 2985213R; CIN: Lancet. 2008 Mar 1;371(9614):699-700. PMID: 18313484; RF: 118; OID: NLM: PMC2262920; ppublish;.
S. Lagakos. The New England journal of medicine, 355 (2):
113-7(July 2006)4860<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; 0 (Cyclooxygenase 2 Inhibitors); 0 (Lactones); 0 (Sulfones); 0 (rofecoxib); CON: N Engl J Med. 2005 Mar 17;352(11):1092-102. PMID: 15713943; 2006/06/26 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
L. Mell, and J. Jeong. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 (28):
4297-9(October 2010)Comparacions múltiples.